|
Volumn 375, Issue 21, 2016, Pages 2013-2015
|
Undermining value-based purchasing - Lessons from the pharmaceutical industry
a,b c d |
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG INDUSTRY;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH CARE ORGANIZATION;
HEALTH CARE PLANNING;
HEALTH INSURANCE;
MEDICARE;
PATIENT SATISFACTION;
PRESCRIPTION;
PRIORITY JOURNAL;
SHORT SURVEY;
UNITED STATES;
COST;
DRUG COST;
ECONOMICS;
FEE;
PURCHASING;
COST SHARING;
DRUG COSTS;
DRUG INDUSTRY;
MEDICARE;
PRESCRIPTION FEES;
UNITED STATES;
VALUE-BASED PURCHASING;
|
EID: 84996588033
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1607378 Document Type: Short Survey |
Times cited : (30)
|
References (5)
|